Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Inari Medical Inc
(NQ:
NARI
)
42.98
-0.24 (-0.57%)
Streaming Delayed Price
Updated: 2:16 PM EDT, Sep 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Inari Medical Inc
< Previous
1
2
3
4
Next >
Inari Medical Earnings Preview
February 24, 2023
Via
Benzinga
Analyst Ratings for Inari Medical
February 21, 2023
Via
Benzinga
3 Magnificent Growth Stocks With 38% to 64% Upside Potential, According to Wall Street
February 12, 2023
Find out why the investment bankers who follow these stocks think they can soar in the near term.
Via
The Motley Fool
Analyst Expectations for Inari Medical's Future
January 31, 2023
Via
Benzinga
3 Beaten-Down Growth Stocks That I'm Loading Up On in 2023
January 21, 2023
These stocks are all down by at least 42% from their all-time highs despite impressive performances from their underlying businesses.
Via
The Motley Fool
3 Remarkable Growth Stocks That Could Climb 39% to 46%, According to Wall Street
January 07, 2023
These companies are reporting financial results that aren't being reflected in their stock market performances.
Via
The Motley Fool
What 6 Analyst Ratings Have To Say About Inari Medical
December 20, 2022
Via
Benzinga
Analyst Ratings for Inari Medical
November 03, 2022
Analysts have provided the following ratings for Inari Medical (NASDAQ:NARI) within the last quarter:
Via
Benzinga
Where Inari Medical Stands With Analysts
September 29, 2022
Analysts have provided the following ratings for Inari Medical (NASDAQ:NARI) within the last quarter:
Via
Benzinga
Inari Medical Q1 Earnings Beat Street View, Lifts FY22 Sales Outlook Above Consensus
May 05, 2022
Via
Benzinga
2 Top Growth Stocks Down 42.6% and 68.5% to Buy Before They Rebound in 2023
December 02, 2022
These relatively reliable healthcare businesses are performing much better than their beaten-down stock prices would suggest.
Via
The Motley Fool
Where Inari Medical Stands With Analysts
October 17, 2022
Over the past 3 months, 6 analysts have published their opinion on Inari Medical (NASDAQ:NARI) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022
October 12, 2022
Upgrades
Via
Benzinga
Inari Medical: Battling Blood Clots
March 19, 2022
Inari Medical is a small medical outfit whose stock has gone through the wringer for nearly a year — but the story remains terrific and the stock is starting to act better. Let's take a closer look.
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2022
September 29, 2022
Upgrades
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 13, 2022
September 13, 2022
Upgrades See all analyst ratings upgrades.
Via
Benzinga
Recap: Inari Medical Q4 Earnings
February 23, 2022
Inari Medical (NASDAQ:NARI) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings...
Via
Benzinga
Morgan Stanley Maintains Overweight Rating for Inari Medical: Here's What You Need To Know
July 15, 2022
Morgan Stanley has decided to maintain its Overweight rating of Inari Medical (NASDAQ:NARI) and lower its price target from $108.00 to $93.00. Shares of Inari Medical are trading up 0.74% over the last...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 21, 2022
June 21, 2022
Upgrades
Via
Benzinga
Inari Medical's Return On Capital Employed Insights
May 23, 2022
Benzinga Pro data, Inari Medical (NASDAQ:NARI) reported Q1 sales of $86.75 million. Earnings fell to a loss of $3.13 million, resulting in a 382.66% decrease from last quarter.
Via
Benzinga
A Preview Of Inari Medical's Earnings
May 03, 2022
Inari Medical (NASDAQ:NARI) is set to give its latest quarterly earnings report on Wednesday, 2022-05-04. Here's what investors need to know before the announcement. Analysts estimate that Inari...
Via
Benzinga
Inari Medical Reports Mixed Q4 Earnings, Guides FY22 Sales Above Consensus
February 24, 2022
Inari Medical Inc's (NASDAQ: NARI) Q4 revenue was $83.2 million, up 14% sequentially and 71% Y/Y, beating the consensus of $78.16 million. The sequential growth was...
Via
Benzinga
The Daily Biotech Pulse: Kodiak Sinks On Adverse Study Outcome, Marinus Flags Delay In Clinical Trial, Mainz Biomed Gains On Positive Regulatory Development
February 23, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Kodiak's Wet AMD Treatment KSI-301 Did Not Meet Primary Endpoint In Phase...
Via
Benzinga
A Preview Of Inari Medical's Earnings
February 22, 2022
Inari Medical (NASDAQ:NARI) is set to give its latest quarterly earnings report on Wednesday, 2022-02-23. Here's what investors need to know before the announcement. Analysts...
Via
Benzinga
30 Stocks Moving In Tuesday's Mid-Day Session
January 11, 2022
Gainers TSR, Inc. (NASDAQ: TSRI) shares climbed 36.6% to $12.21 following Q2 results. The company reported Q2 revenue of $23.9 million, versus $16.1 million year over year....
Via
Benzinga
Earnings Scheduled For February 23, 2022
February 23, 2022
Companies Reporting Before The Bell • Sapiens Intl Corp (NASDAQ:SPNS) is likely to report earnings for its fourth quarter. • Plymouth Industrial REIT (NYSE:PLYM)...
Via
Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front...
Via
Benzinga
The Daily Biotech Pulse: Illunina Announces Multiple Partnerships, Immunome Slides On Regulatory Setback For COVID Antibody Drug, Preannouncements Pour In
January 11, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus BioAtla, Bristol-Myers Squibb Announce Collaboration To Evaluate ADC-Opdivo...
Via
Benzinga
21 Stocks Moving in Tuesday's Pre-Market Session
January 11, 2022
Gainers OneSmart International Education Group Limited (NYSE: ONE) rose 39.1% to $0.2701 in pre-market trading. OneSmart International Education Group received notification from...
Via
Benzinga
Inari Medical Reports Solid Preliminary Q4, FY21 Sales
January 11, 2022
Inari Medical Inc (NASDAQ: NARI) expects Q4 FY21 sales of $82.8 million - $83.3 million, up 14% sequentially and 71% year-over-year (at the midpoint of the range),...
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.